Details of the Drug Combination

General Information of Drug Combination (ID: DC4OLI4)

Drug Combination Name
Zidovudine Lamivudine
Indication
Disease Entry Status REF
Malaria Phase 3 [1]
Component Drugs Zidovudine   DM4KI7O Lamivudine   DMI347A
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Zidovudine
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [2]
Diarrhea ME05.1 Investigative [3]
Nephropathy GC2Z Investigative [3]
Virus infection 1A24-1D9Z Investigative [4]
Zidovudine Interacts with 2 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Human immunodeficiency virus Reverse transcriptase (HIV RT) TT84ETX POL_HV1B1 Inhibitor [12]
Fms-like tyrosine kinase 3 (FLT-3) TTGJCWZ FLT3_HUMAN Binder [13]
------------------------------------------------------------------------------------
Zidovudine Interacts with 8 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [14]
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [15]
Organic anion transporter 2 (SLC22A7) DT0OC1Q S22A7_HUMAN Substrate [16]
Organic cation transporter 1 (SLC22A1) DTT79CX S22A1_HUMAN Substrate [17]
Multidrug resistance-associated protein 4 (ABCC4) DTCSGPB MRP4_HUMAN Substrate [17]
Organic anion transporter 1 (SLC22A6) DTQ23VB S22A6_HUMAN Substrate [16]
Organic anion transporter 3 (SLC22A8) DTVP67E S22A8_HUMAN Substrate [16]
Organic anion transporter 4 (SLC22A11) DT06JWZ S22AB_HUMAN Substrate [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DTP(s)
Zidovudine Interacts with 7 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Metabolism [18]
UDP-glucuronosyltransferase 1A1 (UGT1A1) DEYGVN4 UD11_HUMAN Metabolism [19]
Cytochrome P450 2A6 (CYP2A6) DEJVYAZ CP2A6_HUMAN Metabolism [20]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Metabolism [20]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Metabolism [20]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Metabolism [20]
UDP-glucuronosyltransferase 2B7 (UGT2B7) DEB3CV1 UD2B7_HUMAN Metabolism [21]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DME(s)
Zidovudine Interacts with 223 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Solute carrier family 22 member 7 (SLC22A7) OTKTNH1W S22A7_HUMAN Increases Expression [8]
ATP-binding cassette sub-family C member 4 (ABCC4) OTO27PAL MRP4_HUMAN Increases Expression [22]
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2) OTW8V2V1 ABCG2_HUMAN Increases Expression [8]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Increases Expression [22]
Thymidine kinase 2, mitochondrial (TK2) OTS1V4XB KITM_HUMAN Increases Expression [8]
Erythropoietin (EPO) OTZ90CN4 EPO_HUMAN Increases Expression [23]
Thymidine kinase, cytosolic (TK1) OTY5JFM1 KITH_HUMAN Increases Methylation [24]
Cellular tumor antigen p53 (TP53) OTIE1VH3 P53_HUMAN Increases Expression [25]
Cyclin-dependent kinase inhibitor 1 (CDKN1A) OTQWHCZE CDN1A_HUMAN Decreases Expression [26]
Sodium-dependent phosphate transport protein 3 (SLC17A2) OT5U4CFD NPT3_HUMAN Decreases Expression [8]
Acetyl-CoA carboxylase 2 (ACACB) OT96UIP1 ACACB_HUMAN Affects Expression [27]
Succinate dehydrogenase cytochrome b small subunit, mitochondrial (SDHD) OTYZ8XRH DHSD_HUMAN Increases Expression [28]
Acyl carrier protein, mitochondrial (NDUFAB1) OTF906UR ACPM_HUMAN Increases Expression [28]
Telomerase reverse transcriptase (TERT) OT085VVA TERT_HUMAN Decreases Activity [29]
Serine/threonine-protein kinase Chk1 (CHEK1) OTTTI622 CHK1_HUMAN Decreases Expression [30]
Long-chain fatty acid transport protein 2 (SLC27A2) OT7JEG5F S27A2_HUMAN Increases Expression [8]
Monocarboxylate transporter 5 (SLC16A4) OT1YXBKC MOT5_HUMAN Increases Expression [8]
Monocarboxylate transporter 7 (SLC16A6) OT7BIIZX MOT7_HUMAN Decreases Expression [8]
Monocarboxylate transporter 4 (SLC16A3) OTDIXEXY MOT4_HUMAN Decreases Expression [8]
Protein SLC31A2 (SLC31A2) OTQC136Q COPT2_HUMAN Increases Expression [8]
ATP-binding cassette sub-family C member 3 (ABCC3) OTC3IJV4 MRP3_HUMAN Increases Expression [8]
ATP-binding cassette sub-family C member 5 (ABCC5) OT34G4US MRP5_HUMAN Increases Expression [22]
Phospholipid-transporting ATPase IC (ATP8B1) OTALGS63 AT8B1_HUMAN Decreases Expression [28]
NADH dehydrogenase 1 beta subcomplex subunit 5, mitochondrial (NDUFB5) OTQAA1B8 NDUB5_HUMAN Increases Expression [28]
NADH dehydrogenase 1 beta subcomplex subunit 3 (NDUFB3) OTDV12IF NDUB3_HUMAN Increases Expression [28]
NADH dehydrogenase 1 subunit C1, mitochondrial (NDUFC1) OTJ5TNHB NDUC1_HUMAN Increases Expression [28]
Mitochondrial carnitine/acylcarnitine carrier protein (SLC25A20) OT6CLFXB MCAT_HUMAN Increases Expression [8]
NADH dehydrogenase iron-sulfur protein 5 (NDUFS5) OTF40UYJ NDUS5_HUMAN Increases Expression [28]
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L) OTJKOMXE BNI3L_HUMAN Increases Expression [31]
Thiamine transporter 1 (SLC19A2) OTH5SB0M S19A2_HUMAN Decreases Expression [8]
NADH dehydrogenase iron-sulfur protein 2, mitochondrial (NDUFS2) OTBT8KW9 NDUS2_HUMAN Decreases Expression [28]
NADH dehydrogenase iron-sulfur protein 6, mitochondrial (NDUFS6) OT9IOONQ NDUS6_HUMAN Increases Expression [28]
Citrate synthase, mitochondrial (CS) OTYLYXMO CISY_HUMAN Decreases Expression [32]
ATP synthase subunit g, mitochondrial (ATP5MG) OTD569IJ ATP5L_HUMAN Increases Expression [28]
Organic cation/carnitine transporter 2 (SLC22A5) OTC36TYB S22A5_HUMAN Increases Expression [8]
Solute carrier organic anion transporter family member 2B1 (SLCO2B1) OTERJ4VQ SO2B1_HUMAN Decreases Expression [8]
NADH dehydrogenase 1 beta subcomplex subunit 6 (NDUFB6) OTIXNT91 NDUB6_HUMAN Increases Expression [28]
ATP-binding cassette sub-family C member 6 (ABCC6) OTZT0LKT MRP6_HUMAN Increases Expression [8]
GDH/6PGL endoplasmic bifunctional protein (H6PD) OTO7TNDD G6PE_HUMAN Affects Expression [27]
Solute carrier family 2, facilitated glucose transporter member 10 (SLC2A10) OTL32QH7 GTR10_HUMAN Decreases Expression [8]
Serine/threonine-protein kinase Chk2 (CHEK2) OT8ZPCNS CHK2_HUMAN Decreases Expression [30]
G1/S-specific cyclin-E2 (CCNE2) OTBBUKQQ CCNE2_HUMAN Decreases Expression [26]
Cytochrome b (CYTB) OTAHB98A CYB_HUMAN Affects Expression [27]
Cytochrome c oxidase subunit 2 (COX2) OTTMVBJJ COX2_HUMAN Increases Expression [28]
Cytochrome c oxidase subunit 3 (COX3) OTNNGBYJ COX3_HUMAN Increases Expression [28]
Hypoxanthine-guanine phosphoribosyltransferase (HPRT1) OTOEEEXG HPRT_HUMAN Increases Mutagenesis [33]
Adenosine deaminase (ADA) OTOX2872 ADA_HUMAN Increases Expression [34]
ATP synthase subunit a (ATP6) OTPHOGLX ATP6_HUMAN Increases Expression [28]
Tumor necrosis factor (TNF) OT4IE164 TNFA_HUMAN Decreases Expression [35]
Interferon alpha-1/13 (IFNA1) OTPMKY0L IFNA1_HUMAN Affects Expression [36]
Interferon gamma (IFNG) OTXG9JM7 IFNG_HUMAN Affects Expression [36]
Interleukin-1 alpha (IL1A) OTPSGILV IL1A_HUMAN Increases Expression [37]
Interleukin-1 beta (IL1B) OT0DWXXB IL1B_HUMAN Increases Expression [38]
Interleukin-2 receptor subunit alpha (IL2RA) OT0MWCHG IL2RA_HUMAN Decreases Expression [39]
HLA class I histocompatibility antigen, B alpha chain (HLA-B) OTNXFWY2 HLAB_HUMAN Affects Expression [40]
Albumin (ALB) OTVMM513 ALBU_HUMAN Affects Binding [41]
NADH-ubiquinone oxidoreductase chain 1 (ND1) OTCLGIXV NU1M_HUMAN Increases Expression [28]
NADH-ubiquinone oxidoreductase chain 2 (ND2) OTG9OHOX NU2M_HUMAN Increases Expression [28]
NADH-ubiquinone oxidoreductase chain 4 (ND4) OT4RQVAA NU4M_HUMAN Increases Expression [28]
NADH-ubiquinone oxidoreductase chain 5 (ND5) OT45LW1K NU5M_HUMAN Increases Expression [28]
Glucocorticoid receptor (NR3C1) OTCI2YDI GCR_HUMAN Affects Expression [27]
HLA class I histocompatibility antigen, A alpha chain (HLA-A) OTAH14LU HLAA_HUMAN Affects Expression [40]
Anion exchange protein 2 (SLC4A2) OTLJIEOH B3A2_HUMAN Increases Expression [8]
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) OTM0GDTP IF2A_HUMAN Increases Phosphorylation [42]
Interleukin-6 (IL6) OTUOSCCU IL6_HUMAN Increases Expression [43]
Endothelin-1 (EDN1) OTZCACEG EDN1_HUMAN Increases Secretion [31]
Lipoprotein lipase (LPL) OTTW0267 LIPL_HUMAN Decreases Expression [28]
Adenine phosphoribosyltransferase (APRT) OT5ZUKVF APT_HUMAN Increases Mutagenesis [44]
Amino acid transporter heavy chain SLC3A2 (SLC3A2) OTBR33M9 4F2_HUMAN Increases Expression [8]
P3 protein (SLC10A3) OTUBZ4HT P3_HUMAN Increases Expression [8]
Cytochrome c oxidase subunit 6C (COX6C) OT3V7JE5 COX6C_HUMAN Decreases Expression [45]
Apoptosis regulator Bcl-2 (BCL2) OT9DVHC0 BCL2_HUMAN Decreases Expression [46]
Cytochrome c oxidase subunit 5B, mitochondrial (COX5B) OTDP94F3 COX5B_HUMAN Decreases Expression [45]
60 kDa heat shock protein, mitochondrial (HSPD1) OTTO1Y11 CH60_HUMAN Affects Expression [42]
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1) OTA675TJ GTR1_HUMAN Decreases Expression [8]
Solute carrier family 2, facilitated glucose transporter member 3 (SLC2A3) OT2HZK5M GTR3_HUMAN Decreases Expression [8]
C-C motif chemokine 2 (CCL2) OTAD2HEL CCL2_HUMAN Increases Expression [43]
Cytochrome c oxidase subunit 7A2, mitochondrial (COX7A2) OTVT146E CX7A2_HUMAN Increases Expression [28]
Solute carrier family 2, facilitated glucose transporter member 4 (SLC2A4) OTJZG0LD GLUT4_HUMAN Affects Expression [27]
Fatty acid-binding protein, adipocyte (FABP4) OT3DKFOU FABP4_HUMAN Affects Expression [27]
N-chimaerin (CHN1) OTM196M3 CHIN_HUMAN Decreases Expression [28]
Cytochrome c oxidase subunit 7C, mitochondrial (COX7C) OTREWSBF COX7C_HUMAN Decreases Expression [45]
Erythroid transcription factor (GATA1) OTX1R7O1 GATA1_HUMAN Decreases Expression [47]
Histone H2AX (H2AX) OT18UX57 H2AX_HUMAN Increases Phosphorylation [48]
Solute carrier family 25 member 16 (SLC25A16) OTTTUL91 GDC_HUMAN Increases Expression [8]
ATP synthase-coupling factor 6, mitochondrial (ATP5PF) OTDAE8FP ATP5J_HUMAN Increases Expression [28]
Sodium/hydrogen exchanger 1 (SLC9A1) OT6HNHFV SL9A1_HUMAN Increases Expression [8]
Cyclin-A2 (CCNA2) OTPHHYZJ CCNA2_HUMAN Decreases Expression [26]
Cytochrome c oxidase subunit 5A, mitochondrial (COX5A) OTP0961M COX5A_HUMAN Decreases Expression [45]
Succinate dehydrogenase iron-sulfur subunit, mitochondrial (SDHB) OTRE1M1T SDHB_HUMAN Decreases Expression [28]
Methylmalonyl-CoA mutase, mitochondrial (MMUT) OTBBBV70 MUTA_HUMAN Increases Expression [49]
Sodium-dependent noradrenaline transporter (SLC6A2) OTMHQJMP SC6A2_HUMAN Increases Expression [8]
Cytochrome c oxidase subunit 7A1, mitochondrial (COX7A1) OTHV25GG CX7A1_HUMAN Decreases Expression [45]
Cytochrome c oxidase subunit 7B, mitochondrial (COX7B) OT67PIDP COX7B_HUMAN Increases Expression [28]
G1/S-specific cyclin-D1 (CCND1) OT8HPTKJ CCND1_HUMAN Increases Expression [26]
ATP synthase F(0) complex subunit B1, mitochondrial (ATP5PB) OTPOAAUW AT5F1_HUMAN Increases Expression [28]
Replication protein A 70 kDa DNA-binding subunit (RPA1) OT76POLP RFA1_HUMAN Increases Expression [10]
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (NDUFS1) OTTIZDFR NDUS1_HUMAN Increases Expression [28]
11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1) OTO7FJA9 DHI1_HUMAN Affects Expression [27]
Nitric oxide synthase 3 (NOS3) OTLDT7NR NOS3_HUMAN Decreases Phosphorylation [31]
ATP synthase subunit delta, mitochondrial (ATP5F1D) OTXTAG2V ATPD_HUMAN Decreases Expression [28]
Phosphatidylethanolamine-binding protein 1 (PEBP1) OTQ5FEI0 PEBP1_HUMAN Decreases Expression [28]
G1/S-specific cyclin-D2 (CCND2) OTDULQF9 CCND2_HUMAN Decreases Expression [26]
General transcription factor IIH subunit 1 (GTF2H1) OTCRXC6B TF2H1_HUMAN Increases Expression [10]
Multidrug resistance-associated protein 1 (ABCC1) OTGUN89S MRP1_HUMAN Increases Expression [8]
ATP-binding cassette sub-family D member 1 (ABCD1) OT3FL9W0 ABCD1_HUMAN Increases Expression [8]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [26]
Monocarboxylate transporter 8 (SLC16A2) OTLRA7C0 MOT8_HUMAN Increases Expression [8]
Lon protease homolog, mitochondrial (LONP1) OT665WYT LONM_HUMAN Affects Expression [42]
Chloride anion exchanger (SLC26A3) OTBNK2U2 S26A3_HUMAN Decreases Expression [8]
Leptin (LEP) OT5Q7ODW LEP_HUMAN Decreases Expression [43]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Expression [46]
Cyclin-dependent kinase inhibitor 2A (CDKN2A) OTN0ZWAE CDN2A_HUMAN Increases Expression [25]
Excitatory amino acid transporter 3 (SLC1A1) OT3B9M6W EAA3_HUMAN Increases Expression [8]
Neutral amino acid transporter A (SLC1A4) OTVODHAE SATT_HUMAN Increases Expression [8]
Mitogen-activated protein kinase 8 (MAPK8) OTEREYS5 MK08_HUMAN Increases Phosphorylation [42]
Tumor necrosis factor ligand superfamily member 6 (FASLG) OTZARCHH TNFL6_HUMAN Increases Expression [50]
Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) OT88C8JA SC6A8_HUMAN Decreases Expression [8]
ATP synthase subunit O, mitochondrial (ATP5PO) OTU3MCTN ATPO_HUMAN Increases Expression [28]
Sodium- and chloride-dependent betaine transporter (SLC6A12) OTKOR4F2 S6A12_HUMAN Increases Expression [8]
Sodium- and chloride-dependent GABA transporter 3 (SLC6A11) OT5F9PAE S6A11_HUMAN Increases Expression [8]
ATP synthase F(0) complex subunit C3, mitochondrial (ATP5MC3) OTX674BU AT5G3_HUMAN Increases Expression [28]
Fatty acid synthase (FASN) OTFII9KG FAS_HUMAN Affects Expression [27]
NADH dehydrogenase flavoprotein 1, mitochondrial (NDUFV1) OTEVK4WW NDUV1_HUMAN Decreases Expression [28]
Sulfate transporter (SLC26A2) OTJNHNTO S26A2_HUMAN Increases Expression [8]
Cationic amino acid transporter 2 (SLC7A2) OTAMWBVM CTR2_HUMAN Decreases Expression [8]
Tricarboxylate transport protein, mitochondrial (SLC25A1) OTIDXQ9F TXTP_HUMAN Increases Expression [8]
Sodium/myo-inositol cotransporter (SLC5A3) OT6FY2KA SC5A3_HUMAN Decreases Expression [8]
Monocarboxylate transporter 1 (SLC16A1) OTW1UTZ7 MOT1_HUMAN Decreases Expression [8]
Solute carrier family 12 member 3 (SLC12A3) OTAO2PG6 S12A3_HUMAN Decreases Expression [8]
ATP synthase subunit e, mitochondrial (ATP5ME) OTADVEE2 ATP5I_HUMAN Increases Expression [28]
NADH dehydrogenase 1 alpha subcomplex subunit 6 (NDUFA6) OTEOIIOL NDUA6_HUMAN Increases Expression [28]
Glucose-6-phosphate exchanger SLC37A1 (SLC37A1) OTSYK97W G6PT2_HUMAN Increases Expression [8]
Poly(rC)-binding protein 4 (PCBP4) OTDLL4NB PCBP4_HUMAN Increases Expression [51]
Hemoglobin subunit beta (HBB) OT514IKQ HBB_HUMAN Decreases Expression [52]
Protein BTG2 (BTG2) OTZF6K1H BTG2_HUMAN Increases Expression [51]
b(0,+)-type amino acid transporter 1 (SLC7A9) OTMNY2WA BAT1_HUMAN Increases Expression [8]
Vigilin (HDLBP) OTKDEEYX VIGLN_HUMAN Decreases Expression [28]
E3 ubiquitin-protein ligase Mdm2 (MDM2) OTOVXARF MDM2_HUMAN Increases Expression [25]
Large neutral amino acids transporter small subunit 1 (SLC7A5) OT2WPVXD LAT1_HUMAN Increases Expression [8]
Mitochondrial 2-oxoglutarate/malate carrier protein (SLC25A11) OT7EVFBK M2OM_HUMAN Increases Expression [8]
Hormone-sensitive lipase (LIPE) OTMMVJ8A LIPS_HUMAN Affects Expression [27]
Sodium-dependent phosphate transporter 2 (SLC20A2) OT6E2DAX S20A2_HUMAN Increases Expression [8]
Acetyl-CoA carboxylase 1 (ACACA) OT5CQPZY ACACA_HUMAN Affects Expression [27]
Caspase-8 (CASP8) OTA8TVI8 CASP8_HUMAN Increases Cleavage [50]
Metal cation symporter ZIP14 (SLC39A14) OTGR686L S39AE_HUMAN Decreases Expression [8]
Adiponectin (ADIPOQ) OTNX23LE ADIPO_HUMAN Decreases Expression [43]
Transcription factor NF-E2 45 kDa subunit (NFE2) OTLM94BI NFE2_HUMAN Decreases Expression [47]
NADH dehydrogenase 1 alpha subcomplex subunit 9, mitochondrial (NDUFA9) OTMKQJJ8 NDUA9_HUMAN Increases Expression [28]
ATP-binding cassette sub-family C member 10 (ABCC10) OT2JRWWJ MRP7_HUMAN Increases Expression [8]
Proton-coupled zinc antiporter SLC30A9, mitochondrial (SLC30A9) OT2AN3VH ZNT9_HUMAN Increases Expression [8]
Heme A synthase COX15 (COX15) OTUIYHIW COX15_HUMAN Decreases Expression [28]
Solute carrier family 26 member 9 (SLC26A9) OTCTGDOS S26A9_HUMAN Increases Expression [8]
Ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) OTE8GBUR RIR2B_HUMAN Increases Expression [53]
Sodium-independent sulfate anion transporter (SLC26A11) OTWBV9CR S2611_HUMAN Increases Expression [8]
Na(+)/citrate cotransporter (SLC13A5) OTPH1TA7 S13A5_HUMAN Decreases Expression [8]
Organic anion transporter 7 (SLC22A9) OTO4BJCC S22A9_HUMAN Decreases Expression [8]
Solute carrier family 35 member F2 (SLC35F2) OTSAD4EQ S35F2_HUMAN Increases Expression [8]
Solute carrier family 22 member 15 (SLC22A15) OT60WAAI S22AF_HUMAN Decreases Expression [8]
Solute carrier family 38 member 6 (SLC38A6) OTIC8SHQ S38A6_HUMAN Increases Expression [8]
Phospholipid-transporting ATPase ABCA7 (ABCA7) OT51S50X ABCA7_HUMAN Decreases Expression [8]
Vesicular glutamate transporter 3 (SLC17A8) OTQULEQ4 VGLU3_HUMAN Increases Expression [8]
Zinc transporter 7 (SLC30A7) OTC55IN4 ZNT7_HUMAN Increases Expression [8]
Solute carrier family 2, facilitated glucose transporter member 14 (SLC2A14) OTBFIOVY GTR14_HUMAN Decreases Expression [8]
Glucose-6-phosphate exchanger SLC37A2 (SLC37A2) OTH77FBE G6PT3_HUMAN Increases Expression [8]
Solute carrier family 22 member 17 (SLC22A17) OTLBYGOY S22AH_HUMAN Increases Expression [8]
Sodium-dependent phosphate transporter 1 (SLC20A1) OTC3D894 S20A1_HUMAN Decreases Expression [8]
Sodium-coupled neutral amino acid transporter 5 (SLC38A5) OTX4Q83J S38A5_HUMAN Decreases Expression [8]
Na(+)/dicarboxylate cotransporter 3 (SLC13A3) OTRDOV1Y S13A3_HUMAN Decreases Expression [8]
Solute carrier organic anion transporter family member 2A1 (SLCO2A1) OT3062CA SO2A1_HUMAN Decreases Expression [8]
Major histocompatibility complex class I-related gene protein (MR1) OTZU3XX7 HMR1_HUMAN Affects Expression [40]
Sodium-coupled neutral amino acid transporter 4 (SLC38A4) OTV5OHBT S38A4_HUMAN Decreases Expression [8]
Nucleotide sugar transporter SLC35B4 (SLC35B4) OTPW52JT S35B4_HUMAN Increases Expression [8]
Solute carrier organic anion transporter family member 4A1 (SLCO4A1) OT3J1G7H SO4A1_HUMAN Decreases Expression [8]
Solute carrier family 22 member 18 (SLC22A18) OT9C3KR4 S22AI_HUMAN Increases Expression [8]
Probable UDP-sugar transporter protein SLC35A4 (SLC35A4) OTGDNI2L S35A4_HUMAN Increases Expression [8]
ATP-binding cassette sub-family C member 11 (ABCC11) OTVHL7OR MRP8_HUMAN Increases Expression [8]
Sodium-coupled neutral amino acid symporter 2 (SLC38A2) OTALABSK S38A2_HUMAN Decreases Expression [8]
Bifunctional polynucleotide phosphatase/kinase (PNKP) OTXJNXVW PNKP_HUMAN Increases Expression [51]
Sodium-coupled neutral amino acid transporter 3 (SLC38A3) OTCHH25G S38A3_HUMAN Increases Expression [8]
Probable proton-coupled zinc antiporter SLC30A3 (SLC30A3) OTEY876E ZNT3_HUMAN Increases Expression [8]
Phospholipid-transporting ATPase ABCA3 (ABCA3) OTH6MSKQ ABCA3_HUMAN Increases Expression [8]
Equilibrative nucleoside transporter 1 (SLC29A1) OTLOOZZS S29A1_HUMAN Increases Expression [8]
Mitochondrial 2-oxodicarboxylate carrier (SLC25A21) OTB78IF4 ODC_HUMAN Increases Expression [8]
Solute carrier family 12 member 9 (SLC12A9) OTR7VRAK S12A9_HUMAN Increases Expression [8]
Solute carrier family 2, facilitated glucose transporter member 11 (SLC2A11) OTNC55HX GTR11_HUMAN Increases Expression [8]
Equilibrative nucleoside transporter 3 (SLC29A3) OTGLX8XU S29A3_HUMAN Increases Expression [8]
Thiamine transporter 2 (SLC19A3) OTOWP1CT S19A3_HUMAN Decreases Expression [8]
Solute carrier family 22 member 4 (SLC22A4) OT4LOVI9 S22A4_HUMAN Increases Expression [8]
Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (SLC35B3) OTBDPI8I S35B3_HUMAN Increases Expression [8]
Sulfate anion transporter 1 (SLC26A1) OTBJVDTD S26A1_HUMAN Increases Expression [8]
Solute carrier family 28 member 3 (SLC28A3) OT5TLTYU S28A3_HUMAN Increases Expression [8]
Solute carrier family 40 member 1 (SLC40A1) OT8RV2VY S40A1_HUMAN Increases Expression [8]
ABC-type oligopeptide transporter ABCB9 (ABCB9) OTSOBOL5 ABCB9_HUMAN Increases Expression [8]
Asc-type amino acid transporter 1 (SLC7A10) OTN1S03Q AAA1_HUMAN Decreases Expression [8]
NAD-dependent protein deacetylase sirtuin-3, mitochondrial (SIRT3) OTMEF544 SIR3_HUMAN Increases Expression [42]
Nucleotide sugar transporter SLC35D1 (SLC35D1) OTAQ6YWB S35D1_HUMAN Increases Expression [8]
Zinc transporter ZIP9 (SLC39A9) OTBVVFSK S39A9_HUMAN Increases Expression [8]
ATP-binding cassette sub-family F member 3 (ABCF3) OTLBYTTN ABCF3_HUMAN Increases Expression [8]
Solute carrier family 2, facilitated glucose transporter member 8 (SLC2A8) OTPT2I7B SL2A8_HUMAN Increases Expression [8]
Mitochondrial dicarboxylate carrier (SLC25A10) OTT8647H DIC_HUMAN Increases Expression [8]
ATP-binding cassette sub-family F member 2 (ABCF2) OTXIBZ3N ABCF2_HUMAN Increases Expression [8]
Solute carrier family 23 member 2 (SLC23A2) OTJ5CQMA S23A2_HUMAN Increases Expression [8]
Solute carrier family 2, facilitated glucose transporter member 6 (SLC2A6) OTVUZCLG GTR6_HUMAN Increases Expression [8]
Large neutral amino acids transporter small subunit 2 (SLC7A8) OT8XXVO8 LAT2_HUMAN Increases Expression [8]
Zinc transporter ZIP10 (SLC39A10) OT04411Q S39AA_HUMAN Decreases Expression [8]
Y+L amino acid transporter 1 (SLC7A7) OTYNABBR YLAT1_HUMAN Increases Expression [8]
Solute carrier family 12 member 4 (SLC12A4) OT21JMDH S12A4_HUMAN Increases Expression [8]
Proton-coupled zinc antiporter SLC30A1 (SLC30A1) OTY8J0S4 ZNT1_HUMAN Increases Expression [8]
Cytochrome c oxidase assembly protein COX11, mitochondrial (COX11) OT0N3WL9 COX11_HUMAN Decreases Expression [28]
Interleukin-3 (IL3) OT0CQ35N IL3_HUMAN Increases ADR [54]
ADP/ATP translocase 2 (SLC25A5) OT1XIBMN ADT2_HUMAN Increases ADR [54]
DNA-directed RNA polymerase, mitochondrial (POLRMT) OT5Q8ZUJ RPOM_HUMAN Increases ADR [54]
L-serine dehydratase/L-threonine deaminase (SDS) OT5WTJ2M SDHL_HUMAN Increases ADR [54]
Tumor suppressor ARF (CDKN2A) OTBOQ73Y ARF_HUMAN Increases ADR [54]
p21 protein (HRAS) OTFYE6AJ P78460_HUMAN Increases ADR [54]
Cytochrome c oxidase subunit 1 (COX1) OTG3O9BN COX1_HUMAN Increases ADR [54]
Thymidylate kinase (DTYMK) OTJXYQYK KTHY_HUMAN Affects Response To Substance [55]
Replicase polyprotein 1ab (rep) OTMJ5H6Y R1AB_SARS Increases ADR [54]
Nuclear respiratory factor 1 (NRF1) OTOXWNV8 NRF1_HUMAN Increases ADR [54]
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (COX4I1) OTU0FC24 COX41_HUMAN Increases ADR [54]
NADH-cytochrome b5 reductase 3 (CYB5R3) OTUGT3G8 NB5R3_HUMAN Increases ADR [54]
Sodium/nucleoside cotransporter 1 (SLC28A1) OTXWVV9O S28A1_HUMAN Affects Transport [56]
------------------------------------------------------------------------------------
⏷ Show the Full List of 223 DOT(s)
Indication(s) of Lamivudine
Disease Entry ICD 11 Status REF
Chronic HBV infection 1E51.0Z Approved [5]
Chronic hepatitis B virus infection N.A. Approved [6]
Human immunodeficiency virus infection 1C62 Approved [5]
Human immunodeficiency virus-1 infection 1C62 Approved [7]
Diarrhea ME05.1 Investigative [6]
Lamivudine Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Human immunodeficiency virus Reverse transcriptase (HIV RT) TT84ETX POL_HV1B1 Modulator [57]
------------------------------------------------------------------------------------
Lamivudine Interacts with 3 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [58]
Organic cation transporter 2 (SLC22A2) DT9IDPW S22A2_HUMAN Substrate [59]
Organic cation transporter 1 (SLC22A1) DTT79CX S22A1_HUMAN Substrate [60]
------------------------------------------------------------------------------------
Lamivudine Interacts with 3 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Deoxy-5'-nucleotidase 1 (NT5C) DE4E31Z NT5C_HUMAN Metabolism [61]
Phosphorylcholine transferase A (PCYT1A) DEQYXD4 PCY1A_HUMAN Metabolism [62]
Phosphorylethanolamine transferase (PCYT2) DEIX1PO PCY2_HUMAN Metabolism [62]
------------------------------------------------------------------------------------
Lamivudine Interacts with 19 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Solute carrier family 22 member 2 (SLC22A2) OTGFK1AL S22A2_HUMAN Increases Uptake [63]
Solute carrier family 22 member 1 (SLC22A1) OT7817I4 S22A1_HUMAN Increases Uptake [63]
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L) OTJKOMXE BNI3L_HUMAN Increases Expression [31]
G1/S-specific cyclin-E2 (CCNE2) OTBBUKQQ CCNE2_HUMAN Decreases Expression [26]
Metalloproteinase inhibitor 1 (TIMP1) OTOXC51H TIMP1_HUMAN Decreases Expression [64]
Transforming growth factor beta-1 proprotein (TGFB1) OTV5XHVH TGFB1_HUMAN Decreases Expression [64]
Interferon gamma (IFNG) OTXG9JM7 IFNG_HUMAN Increases Expression [65]
Collagen alpha-1(III) chain (COL3A1) OTT1EMLM CO3A1_HUMAN Decreases Expression [66]
Albumin (ALB) OTVMM513 ALBU_HUMAN Affects Binding [41]
Interstitial collagenase (MMP1) OTI4I2V1 MMP1_HUMAN Increases Expression [64]
Endothelin-1 (EDN1) OTZCACEG EDN1_HUMAN Increases Secretion [31]
Cyclin-A2 (CCNA2) OTPHHYZJ CCNA2_HUMAN Decreases Expression [26]
Nitric oxide synthase 3 (NOS3) OTLDT7NR NOS3_HUMAN Decreases Phosphorylation [31]
G1/S-specific cyclin-D2 (CCND2) OTDULQF9 CCND2_HUMAN Decreases Expression [26]
Sodium-dependent serotonin transporter (SLC6A4) OT6FGDLW SC6A4_HUMAN Increases Expression [67]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [26]
Cyclin-dependent kinase inhibitor 1 (CDKN1A) OTQWHCZE CDN1A_HUMAN Decreases Expression [26]
Actin, aortic smooth muscle (ACTA2) OTEDLG8E ACTA_HUMAN Decreases Expression [66]
Solute carrier family 22 member 3 (SLC22A3) OTQYGVXX S22A3_HUMAN Increases Uptake [63]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 DOT(s)

Test Results of This Drug Combination in Other Disease Systems

Indication DrugCom ID Cell Line Status REF
Human Immunodeficiency Virus DCPC7VB N. A. Phase 3 [68]
HIV Infections DCZJZHV N. A. Phase 3 [69]
HIV Infections DCGON3K N. A. Phase 2 [70]
HIV DCH0XO7 N. A. Phase 1 [71]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00993031) Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4825).
3 Zidovudine FDA Label
4 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
5 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
6 Lamivudine FDA Label
7 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
8 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
9 Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity. Cancer Lett. 2006 Dec 8;244(2):239-46.
10 XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells. Toxicol Appl Pharmacol. 2011 Mar 1;251(2):155-62. doi: 10.1016/j.taap.2010.12.009. Epub 2010 Dec 28.
11 Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Antivir Ther. 2003 Aug;8(4):323-31.
12 Antiviral drugs in current clinical use. J Clin Virol. 2004 Jun;30(2):115-33.
13 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1807).
14 The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res. 2009 May;82(2):A99-109.
15 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
16 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
17 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
18 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
19 Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation. J Clin Pharmacol. 2009 Sep;49(9):1079-90.
20 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
21 Determination of UDP-glucuronosyltransferase UGT2B7 activity in human liver microsomes by ultra-performance liquid chromatography with MS detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):84-90.
22 ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages. Antivir Ther. 2004 Aug;9(4):519-28.
23 Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med. 1988 Mar;108(3):372-6. doi: 10.7326/0003-4819-108-3-372.
24 AZT-induced hypermethylation of human thymidine kinase gene in the absence of total DNA hypermethylation. FEBS Lett. 1996 Nov 4;396(2-3):323-6. doi: 10.1016/0014-5793(96)01124-6.
25 Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
26 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
27 Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months. Antivir Ther. 2009;14(8):1089-100. doi: 10.3851/IMP1457.
28 Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen. 2007 Apr-May;48(3-4):179-89. doi: 10.1002/em.20245.
29 Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma. Endocr Relat Cancer. 2006 Mar;13(1):79-93. doi: 10.1677/erc.1.00988.
30 Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes. Toxicol Sci. 2009 Sep;111(1):120-30. doi: 10.1093/toxsci/kfp136. Epub 2009 Jun 18.
31 Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323-34. doi: 10.1093/toxsci/kft105. Epub 2013 May 2.
32 Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 1991 Jun;29(6):606-14. doi: 10.1002/ana.410290607.
33 Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res. 1999 Oct 19;429(2):249-59. doi: 10.1016/s0027-5107(99)00111-6.
34 Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine. AIDS. 1990 Aug;4(8):799-802. doi: 10.1097/00002030-199008000-00012.
35 Tumor necrosis factor-alpha production-regulating activity of phthalimide derivatives in genetically modified murine melanoma cells B78H1. Farmaco. 2003 May;58(5):371-6. doi: 10.1016/S0014-827X(03)00049-1.
36 Effect of zidovudine therapy in patients with HIV infection on endogenous interferon plasma levels and the hepatic cytochrome P450 enzyme system. Chemotherapy. 1998 May-Jun;44(3):174-80. doi: 10.1159/000007112.
37 Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. Ann Neurol. 1994 Nov;36(5):752-8. doi: 10.1002/ana.410360511.
38 Interleukin (IL)-1 beta and IL-1 beta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. J Neuropathol Exp Neurol. 1997 Jun;56(6):651-63.
39 Down-regulation of interleukin-2 receptor gene activation and protein expression by dideoxynucleoside analogs. Cell Immunol. 1995 Jul;163(2):289-95. doi: 10.1006/cimm.1995.1128.
40 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
41 Binding of anti-HIV drugs to human serum albumin. IUBMB Life. 2004 Oct;56(10):609-14. doi: 10.1080/15216540400016286.
42 Lon protease and eiF2 are involved in acute, but not prolonged, antiretroviral induced stress response in HepG2 cells. Chem Biol Interact. 2016 May 25;252:82-6. doi: 10.1016/j.cbi.2016.03.021. Epub 2016 Apr 1.
43 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
44 Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine. Mutagenesis. 2000 Sep;15(5):405-10. doi: 10.1093/mutage/15.5.405.
45 Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy. J Neurol Sci. 1994 Sep;125(2):190-3. doi: 10.1016/0022-510x(94)90034-5.
46 Effects of AZT and RNA-protein complex (FA-2-b-beta) extracted from Liang Jin mushroom on apoptosis of gastric cancer cells. World J Gastroenterol. 2007 Aug 21;13(31):4185-91. doi: 10.3748/wjg.v13.i31.4185.
47 3'-Azido-3'-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells. Eur J Haematol. 1996 Jan-Feb;56(1-2):62-7. doi: 10.1111/j.1600-0609.1996.tb00296.x.
48 Dynamically monitoring cellular -H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds. Arch Toxicol. 2021 Nov;95(11):3559-3573. doi: 10.1007/s00204-021-03156-3. Epub 2021 Sep 12.
49 Gene induction for the treatment of methylmalonic aciduria. J Gene Med. 2009 Apr;11(4):361-9. doi: 10.1002/jgm.1297.
50 Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicol In Vitro. 2016 Sep;35:66-76. doi: 10.1016/j.tiv.2016.05.013. Epub 2016 May 26.
51 Role of DNA Repair Pathways in Response to Zidovudine-induced DNA Damage in Immortalized Human Liver THLE2 Cells. Int J Biomed Sci. 2013 Mar;9(1):18-25.
52 Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells. Antiviral Res. 1999 Dec 31;44(3):167-77. doi: 10.1016/s0166-3542(99)00065-0.
53 Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells. Mutat Res. 2011 Sep 18;724(1-2):76-85. doi: 10.1016/j.mrgentox.2011.06.003. Epub 2011 Jun 17.
54 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
55 Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system. Redox Biol. 2017 Oct;13:407-417.
56 Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J Physiol. 1997 Feb;272(2 Pt 1):C707-14. doi: 10.1152/ajpcell.1997.272.2.C707.
57 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
58 The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine. Br J Clin Pharmacol. 2007 Nov;64(5):645-54.
59 Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake. Biopharm Drug Dispos. 2012 Apr;33(3):170-8.
60 Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Drug Metab Dispos. 2008 Aug;36(8):1616-23.
61 Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res. 2010 Jan;85(1):39-58.
62 Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents. Antimicrob Agents Chemother. 2006 Aug;50(8):2686-94.
63 Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther. 2009 Apr;329(1):252-61. doi: 10.1124/jpet.108.146225. Epub 2009 Jan 13.
64 Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B. World J Gastroenterol. 2004 Sep 15;10(18):2661-5. doi: 10.3748/wjg.v10.i18.2661.
65 Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology. 2005 Nov;42(5):1028-36. doi: 10.1002/hep.20888.
66 Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol. 2001 Dec;35(6):749-55. doi: 10.1016/s0168-8278(01)00218-5.
67 Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells. Scand J Immunol. 2006 Feb;63(2):106-15. doi: 10.1111/j.1365-3083.2005.01715.x.
68 ClinicalTrials.gov (NCT03988452) Nucleosides And Darunavir/Dolutegravir In Africa
69 ClinicalTrials.gov (NCT02181933) Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women
70 ClinicalTrials.gov (NCT00307151) Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
71 ClinicalTrials.gov (NCT00960622) Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects